A PET scan of the brain in Alzheimer’s disease shows patterns of brain activity and, with certain tracers, the buildup of specific proteins. It reveals areas where brain cells are using less glucose than normal, and it can detect amyloid plaques and tau tangles — the two hallmark proteins linked to Alzheimer’s. These images help doctors distinguish Alzheimer’s from other causes of memory loss, though a PET scan alone is not enough to make the diagnosis.
What Do PET Scans Show in Alzheimer’s Disease?
PET stands for positron emission tomography. It uses a small amount of a radioactive tracer injected into the bloodstream. The tracer travels to the brain, and a scanner detects where it accumulates.
Different tracers reveal different things. The three main types used in Alzheimer’s research and clinical practice are:
- FDG-PET — measures glucose metabolism. Brain cells use glucose for energy. Where cells are dying or functioning poorly, glucose use drops.
- Amyloid PET — detects beta-amyloid plaques, the sticky protein fragments that accumulate between brain cells.
- Tau PET — detects tau tangles, abnormal clumps of a protein that form inside brain cells.
Each type answers a different question. FDG-PET shows how well the brain is working. Amyloid and tau PET show what proteins are building up. Together they give a more complete picture than any single scan.
What Does an FDG-PET Scan Reveal?
FDG-PET shows reduced glucose metabolism in specific brain regions. In Alzheimer’s disease, the pattern is fairly characteristic: lower activity in the temporal and parietal lobes, and often in the posterior cingulate and precuneus areas. The frontal lobes may also be affected as the disease progresses.
This pattern matters because it differs from other forms of dementia. In frontotemporal dementia, metabolism drops mainly in the frontal and anterior temporal lobes. In Lewy body dementia, the visual cortex often shows reduced activity. These differences help clinicians tell one condition from another.
One important nuance: FDG-PET changes reflect neuronal function, not necessarily neuronal death. Some areas may show reduced metabolism before significant cell loss occurs. This means the scan can pick up functional changes early, but it cannot tell you exactly how many neurons have been lost.
FDG-PET is also not specific to Alzheimer’s. Any condition that impairs brain cell function in those regions — including some infections, inflammation, or other neurodegenerative diseases — can produce a similar pattern. The scan is a tool, not a verdict.
What Does Amyloid PET Show?
Amyloid PET detects beta-amyloid plaques in the brain. A positive scan means plaques are present at levels above a certain threshold. A negative scan means they are largely absent.
This sounds straightforward, but the interpretation is complicated. Many people with amyloid plaques never develop dementia. Autopsy studies have found that a substantial proportion of older adults with normal cognition have amyloid plaques at death. The plaques are associated with Alzheimer’s, but they are not sufficient on their own to cause it.
A negative amyloid PET is more informative than a positive one. If no plaques are present, Alzheimer’s disease is very unlikely to be the cause of a person’s memory problems. A positive scan tells you plaques exist, but it does not confirm that Alzheimer’s is causing the symptoms.
Amyloid PET is approved for clinical use in the United States to help evaluate patients with cognitive impairment. It is not recommended as a screening test for people without symptoms.
What Does Tau PET Show?
Tau PET detects tau tangles, which form inside neurons. Tau pathology correlates more closely with cognitive decline than amyloid does. Where tau spreads in the brain tends to match where symptoms appear.
Early tau accumulation typically begins in the medial temporal lobe, an area important for memory. As tau spreads to other regions, symptoms widen to include language, spatial awareness, and executive function.
Tau PET is a newer tool. It is used mainly in research settings. Some tracers have limitations — they may not bind equally well to all forms of tau, and they can show nonspecific signals in certain brain regions. Clinical use is growing but remains less established than amyloid PET.
How Do PET Scans Compare to Other Brain Imaging?
PET scans are not the only way to look at the brain in Alzheimer’s. MRI and CT scans show structure — they reveal shrinkage, strokes, tumors, or fluid buildup. PET shows function and protein buildup.
These techniques answer different questions. A structural scan might show hippocampal atrophy, which is common in Alzheimer’s. But it cannot show whether amyloid or tau is present. A PET scan can.
| Imaging Type | What It Shows | Main Use in Alzheimer’s |
|---|---|---|
| MRI | Brain structure, volume | Detects atrophy, rules out other causes |
| CT | Brain structure | Quick structural check, rules out stroke or tumor |
| FDG-PET | Glucose metabolism | Shows functional patterns of reduced activity |
| Amyloid PET | Beta-amyloid plaques | Detects or rules out amyloid buildup |
| Tau PET | Tau tangles | Maps tau spread (mostly research) |
In practice, a doctor may order more than one type. An MRI to rule out structural problems, then an FDG-PET or amyloid PET if the diagnosis remains unclear.
When Are PET Scans Used in Alzheimer’s Diagnosis?
PET scans are not routine for every person with memory complaints. They are typically used when the diagnosis is uncertain after clinical evaluation and standard testing.
A typical workup includes a medical history, cognitive testing, blood tests to rule out reversible causes like thyroid problems or vitamin deficiencies, and often a structural MRI. If the picture is still unclear — especially in younger patients or those with atypical symptoms — a PET scan may be ordered.
The goal is to distinguish Alzheimer’s from other conditions that can cause similar symptoms. These include:
- Frontotemporal dementia
- Lewy body dementia
- Vascular dementia
- Depression-related cognitive impairment
- Normal pressure hydrocephalus
Getting the right diagnosis matters. Some conditions are treatable. Others have different trajectories and require different care approaches. A PET scan can tip the balance when other tests are inconclusive.
What PET Scans Cannot Tell You
A PET scan cannot predict exactly how fast Alzheimer’s will progress in any individual. It cannot tell you how many years of independence remain. It cannot measure the person’s day-to-day experience of the disease.
Amyloid PET has a particular limitation: a positive result does not mean Alzheimer’s is definitely causing the symptoms. It means the protein is present. Clinical correlation is always needed.
FDG-PET has the opposite limitation: it shows reduced metabolism, but it does not show why. The cause could be Alzheimer’s, another neurodegenerative disease, or something else entirely.
Tau PET, while promising, is not yet a routine clinical tool. Its role in diagnosis and treatment monitoring is still being defined.
No scan replaces a thorough clinical evaluation by a physician experienced in cognitive disorders.
How Does PET Imaging Fit Into Alzheimer’s Research?
PET scans have become central to Alzheimer’s research. They allow scientists to study the disease in living people rather than relying solely on autopsy findings.
Researchers use PET to track how amyloid and tau accumulate over time, to identify who might be at risk before symptoms appear, and to measure whether experimental treatments affect protein buildup.
Some trials have used amyloid PET as a marker to select participants or to measure treatment response. Whether reducing amyloid on a scan translates to meaningful clinical benefit for patients is a separate question — one that has been debated for years and remains an area of active investigation.
For now, PET imaging in Alzheimer’s serves two main purposes: helping clinicians diagnose challenging cases, and helping researchers understand the disease better. Both roles continue to evolve.
Frequently Asked Questions
What does a PET scan show in Alzheimer’s disease?
A PET scan shows reduced glucose metabolism in certain brain regions and, with specific tracers, the presence of amyloid plaques or tau tangles. These findings support a diagnosis but do not confirm it on their own.
Can a PET scan diagnose Alzheimer’s?
A PET scan can support the diagnosis when combined with clinical evaluation and other tests, but it is not used alone to diagnose Alzheimer’s. A positive amyloid scan means plaques are present, not that Alzheimer’s is definitely causing symptoms.
Is a PET scan better than an MRI for Alzheimer’s?
They show different things. MRI shows brain structure and can rule out strokes or tumors. PET shows brain function and protein buildup. Neither is universally better — the choice depends on what question needs answering.
Do you need a PET scan to confirm Alzheimer’s?
No. Many people are diagnosed through clinical evaluation, cognitive testing, and structural imaging without a PET scan. PET is typically reserved for cases where the diagnosis remains uncertain after standard workup.
